Your shopping cart is currently empty

IDO1-IN-30 (Compound (R)-100) is a potent and highly selective inhibitor of IDO1. It exhibits an IC50 value of 4.8 nM against IDO1 in SKOV3 cells. In HepG2 cells, at a concentration of 25 µM, IDO1-IN-30 does not display significant cytotoxicity. Additionally, it eliminates inhibition of CYP450 enzymes, including 3A4, 2C9, and 2D6. This compound is suitable for research related to cancer and inflammatory diseases.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | IDO1-IN-30 (Compound (R)-100) is a potent and highly selective inhibitor of IDO1. It exhibits an IC50 value of 4.8 nM against IDO1 in SKOV3 cells. In HepG2 cells, at a concentration of 25 µM, IDO1-IN-30 does not display significant cytotoxicity. Additionally, it eliminates inhibition of CYP450 enzymes, including 3A4, 2C9, and 2D6. This compound is suitable for research related to cancer and inflammatory diseases. |
| Molecular Weight | 398.37 |
| Formula | C19H16F2N6O2 |
| Cas No. | 2581050-29-3 |
| Smiles | [C@@H](O)(C1=C(N=CC=2N1C=NC2)C3CC3)C4=CN(N=N4)C5=C(F)C=C(OC)C(F)=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.